Skip to main content
Burbank, CA818-842-8887
Menu
Open Reservation Widget
View Menu
    • Remind me later
    • Cancel
    By submitting this form, you consent to share your personal information with us to service your request and for communication purposes. We do not sell your data to third parties. If you are below 16 years of age, you are required to obtain prior permission from your legal guardian(s). If you wish to access or erase your personal information, you can do so by submitting your details Click to erase your personal information
  • By submitting this form, you consent to share your personal information with us to service your request and for communication purposes. We do not sell your data to third parties. If you wish to access or erase your personal information, you can do so by submitting your details Click to erase your personal information.

Back to All Events
Other
November 12, 2021 to November 13, 2021
2:00 PM - 4:30 PM
Sofitel Los Angeles at Beverly Hills, 8555 Beverly Boulevard,, Los Angeles County, California, United States, 90048
Get Directions from Hotel Add to 10th Annual New Therapeutics in Oncology my Calendar

About This Event

This important educational activity will provide guidance to front-line and oncology clinicians, nurses, physicians, pharmacists, nurse practitioners, physician assistants and pharmacists, with the most current information available about new agents in oncology and translating of the latest research to their patients. The conference will cover drug and treatment updates with a focus on myeloma, gynecological malignancies, hematologic malignancies, sarcoma, bladder cancer and GI malignancies. The conference features a comprehensive review of new drugs approved along with their mechanism of action, next generation CAR cell therapies and a keynote lecture outlining advances in immunotherapy. Next generation studies will also be addressed, and the conference will offer participants a session designed to provide insight into the latest advances in lung cancer treatment, including integration of new molecularly-targeted therapies and immunotherapy.